<p>Hemostemix will present at the Small Cap Growth Virtual Investor Conference on November 19, 2026, with President and CEO Thomas Smeenk scheduled to speak at 12:00 p.m. ET. The post Hemostemix&#8217;s Commercial-phase 1 longevity treatment highlighted at conference appeared first on Longevity.Technol</p>